Generating evidence for diagnosis and therapy of RarE LIVEr disease: the RELIVE Initiative for systematic reviews and meta-analyses

Rare liver lesions and diseases have seldomly aroused major interest of researchers. For most guidelines, presumably similar clinical conditions are pooled without detailed investigations of singularities that they present.

Saved in:

Bibliographic Details
Main Authors:	Fuchs, Juri (Author) , Murtha-Lemekhova, Anastasia (Author) , Pfeiffenberger, Jan (Author) , Fichtner, Alexander (Author) , Günther, Patrick (Author) , Halama, Niels (Author) , Mayer, Philipp (Author) , Hornuß, Daniel (Author) , Klotz, Rosa (Author) , Probst, Pascal (Author) , Hoffmann, Katrin (Author)
Format:	Article (Journal)
Language:	English
Published:	03 November 2022
In:	Systematic Reviews Year: 2022, Volume: 11, Pages: 1-3
ISSN:	2046-4053
DOI:	10.1186/s13643-022-02105-0
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13643-022-02105-0
Author Notes:	Juri Fuchs, Anastasia Murtha-Lemekhova, Jan Pfeiffenberger, Alexander Fichtner, Patrick Günther, Niels Halama, Philipp Mayer, Daniel Hornuss, Rosa Klotz, Pascal Probst, Katrin Hoffmann and for the RELIVE Initiative

Description
Summary:	Rare liver lesions and diseases have seldomly aroused major interest of researchers. For most guidelines, presumably similar clinical conditions are pooled without detailed investigations of singularities that they present.
Item Description:	Gesehen am 17.02.2023
Physical Description:	Online Resource
ISSN:	2046-4053
DOI:	10.1186/s13643-022-02105-0